BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile

 

Seikagaku Corporation 

1-5 Nihonbashi-honcho, 2-chome

Chuo-ku  Tokyo  103-0023  Japan
Phone: 81-3-3270-0966 Fax: 81-3-3270-0538


SEARCH JOBS

View Clinical Trials from BioPharm Insight



Industry
Biotechnology






 Company News
Can-Fite BioPharma: Seikagaku Corporation, the Exclusive Licensee of CF101 in Japan, Is to Commence Phase I Clinical Trial in Japan With CF101 for the Treatment of Rheumatoid Arthritis 8/18/2008 8:46:37 AM    More...
Can-Fite BioPharma Progresses Through Clinical Trials: Completed Enrollment Of Half The Patients Required For Phase IIb RA Trial And Is Scheduled To Receive Next Payment Fom The Japanese Seikagaku Corporation 10/23/2006 10:59:23 AM    More...
Seikagaku Corporation Obtains Sales Distribution Approval For MukoUp 10/20/2006 12:44:07 PM    More...
Can-Fite BioPharma Out Licenses Rights For Its Drug, CF101, In Japan To The Seikagaku Corporation And Expects To Receive US$ 19.5 Million From Licensing Fees And Milestone Payments And Collect Substantial Royalties 9/25/2006 10:26:52 AM    More...
Seikagaku Corporation To Begin Clinical Trials Of Injectable Hyaluronic Acid Gel For Knee Osteoarthritis Treatment In US 7/20/2006 7:34:29 PM    More...
Discovery Partners International Inc. (DPII) Announces Receipt Of Success Milestone Payment In Its Lead Finding Collaboration With Seikagaku Corporation 11/9/2005 10:46:51 AM    More...